# Jellagen

producing jellyfish-derived Collagen Type Zero, formed a strategic partnership with US-based Royal Biologics in early 2026 to commercialize the material for the North American regenerative-medicine market, covering wound care and tissue-engineering applications.

Source: https://en.bioecon.ru/companies/jellagen/
Updated: 2026-07-05

- Country: United Kingdom

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Headcount | 18 employees | https://bringo.co.uk/company/435496, https://jellagen.co.uk/about/our-company/, https://uk.globaldatabase.com/company/jellagen-limited |
| Certification | ISO 13485:2016 certification | https://jellagen.co.uk/about/our-company/, https://jellagen.co.uk/collagen-type-0/, https://jellagen.co.uk/files/documents/Whitepapers/Collagen-Type-0-Whitepaper-Web.pdf |
| Production site | A 10,000 square-foot R&D and manufacturing facility in Cardiff, Wales | https://jellagen.co.uk/about/our-company/, https://jellagen.co.uk/collagen-type-0/, https://jellagen.co.uk/files/documents/Whitepapers/Collagen-Type-0-Whitepaper-Web.pdf, https://www.mdpi.com/2310-2861/9/3/247 |
| Capacity | Potential to be manufactured from any jellyfish species at huge scale [medium confidence] | https://jellagen.co.uk/files/documents/Whitepapers/Collagen-Type-0-Whitepaper-Web.pdf |
| Regulatory approval | Currently in product development toward human trials and regulatory filing [medium confidence] | https://jellagen.co.uk/about/jellagen-news/news/jellagen-closes-8.7m-series-a-funding-round-to-accelerate-development-of-collagen-type-0-and-revolutionise-regenerative-medicine |

Independent sources: bringo.co.uk, mdpi.com, uk.globaldatabase.com

## Technologies

- [Recombinant collagen & gelatin](https://en.bioecon.ru/technology/recombinant-collagen-gelatin/)